+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells



Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells



Experimental and Therapeutic Medicine 13(4): 1456-1464



Mesenchymal stem cells (MSCs) have been considered as hypo-immunogenic and immunosuppressive. However, a thorough understanding of the immunological properties after MSC differentiation in vitro and in vivo has not been reached. We asked whether it would be immunogenic after differentiation or influenced by the immune microenvironment after transplantation. In different disease models, the immunological changes of MSCs after differentiation greatly varied, with contradicting results. In order to clarify this, we used a modified four-step induction method to induce human umbilical cord MSCs (hUCMSCs) to differentiate into insulin-producing cells (IPCs), and investigate the immunological changes after differentiation and immune reactions after transplantation into diabetic mice. We found that the induced IPCs are hypo-immunogenic, lacking HLA-DR, CD40 and CD80 expression. Of note, we observed immune cell infiltration to peritoneal cavity and left kidney capsule after local transplantation of induced IPCs. This indicated that hUCMSC-derived IPCs maintained hypo-immunogenic in vitro, but became immunogenic after transplanting to the host, possibly due to the changes of immune microenvironment and thereafter immunological enhancement and immune cell infiltration.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059833147

Download citation: RISBibTeXText

PMID: 28413492

DOI: 10.3892/etm.2017.4096


Related references

Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. Chinese Medical Journal 124(10): 1534-1539, 2011

Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplantation 21(6): 1321-1339, 2012

Extracellular matrix gel is necessary for in vitro cultivation of insulin producing cells from human umbilical cord blood derived mesenchymal stem cells. Chinese Medical Journal 121(9): 811-818, 2008

Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro. Chinese Medical Journal 123(5): 606-614, 2010

Impact of adipose tissue or umbilical cord derived mesenchymal stem cells on the immunogenicity of human cord blood derived endothelial progenitor cells. Plos one 12(5): E0178624, 2017

Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice. Cell Transplantation 20(3): 455-466, 2011

Improved differentiation of umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells by PDX-1 mRNA transfection. Differentiation; Research in Biological Diversity 87(5): 200-208, 2014

Mechanism study for hypoxia induced differentiation of insulin-producing cells from umbilical cord blood-derived mesenchymal stem cells. Biochemical and Biophysical Research Communications 466(3): 444-449, 2015

In Vitro Differentiation of Human Umbilical Cord Blood CD133(+)Cells into Insulin Producing Cells in Co-Culture with Rat Pancreatic Mesenchymal Stem Cells. Cell Journal 17(2): 211-220, 2015

Immunogenicity of Human Umbilical Cord Blood Derived Mesenchymal Stem Cells After Osteogenic Induction. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 28(6): 752-757, 2014

Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro. International Journal of Molecular Medicine 28(6): 1019-1024, 2011

Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo. Biochemical and Biophysical Research Communications 446(4): 983-989, 2014

Study on differentiation of mesenchymal stem cells derived from human umbilical cord blood into insulin secreting cells. Zhonghua Xue Ye Xue Za Zhi 29(10): 679-683, 2008

Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells. In Vitro Cellular and Developmental Biology. Animal 47(1): 54-63, 2011

Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34⁺ cells in a rabbit model of myocardial infarction. MolecularandCellularBiochemistry387(1-2):91, 2014